#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	17270	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2018	847.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1410	1410	C	1028	C,T,A	935,2,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	17270	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2018	847.9	0	HET	.	.	.	T1412TGGGGG,TGGGGGG	.	1412	1412	T	1638	1638	T	1004	TGGGGG,TGGGGGG	470,421	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	17270	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2018	847.9	0	HET	.	.	.	C1525T	.	1525	1525	C	1751	1751	C	850	C,T	426,340	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31378	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3509	890.8	0	.	n	.	0	T695C	SNP	695	695	T	986	986	C	923	C,T,A	855,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31378	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3509	890.8	0	.	n	.	0	A1638G	SNP	1638	1638	A	1929	1929	G	1036	G,A	949,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31378	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3509	890.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2262	2262	C	986	C,T	896,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31378	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3509	890.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2336	2336	A	984	A	914	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31378	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3509	890.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2888	2888	C	978	C	906	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	31378	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3509	890.8	0	HET	.	.	.	A412G	.	412	412	A	703	703	A	1001	A,G	692,200	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2162	folP	855	855	100.0	folP.l15.c4.ctg.1	1500	143.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1006	1008	AGC	219;218;220	A;G;C	203;201;201	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5710	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3424	166.2	1	SNP	p	S91F	1	.	.	271	273	TTC	615	617	TTC	190;186;190	T;T;C	174;171;176	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5710	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3424	166.2	1	SNP	p	G95N	0	.	.	283	285	GGC	627	629	GGC	195;195;195	G;G;C	182;180;179	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5710	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3424	166.2	1	SNP	p	D95G	1	.	.	283	285	GGC	627	629	GGC	195;195;195	G;G;C	182;180;179	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1756	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1369	127.8	0	.	p	.	0	F184L	NONSYN	550	552	TTC	922	924	TTG	195;197;200	T;T;G	179;181;179	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1756	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1369	127.8	1	SNP	p	G45D	0	.	.	133	135	GGC	505	507	GGC	231;227;229	G;G;C	211;207;213	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	934	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1036	90.0	0	.	n	.	0	A197.	DEL	197	197	A	645	645	A	215	A	205	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5702	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2920	194.4	1	SNP	p	D86N	0	.	.	256	258	GAC	606	608	GAC	235;236;237	G;A;C	217;219;222	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5702	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2920	194.4	1	SNP	p	R87W	0	.	.	259	261	CGT	609	611	CGT	235;232;234	C;G;T	219;216;211	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5702	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2920	194.4	1	SNP	p	R87I	0	.	.	259	261	CGT	609	611	CGT	235;232;234	C;G;T	219;216;211	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5702	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2920	194.4	1	SNP	p	S87R	1	.	.	259	261	CGT	609	611	CGT	235;232;234	C;G;T	219;216;211	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5702	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2920	194.4	1	SNP	p	S88P	0	.	.	262	264	TCC	612	614	TCC	236;235;235	T;C;C	214;212;216	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4866	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2616	184.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1513	1515	GGC	219;220;221	G;G;C	200;201;198	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4454	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2296	192.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1198	1200	GCA	233;229;230	G,C;C,A;A	212,1;207,1;210	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4454	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2296	192.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1201	1203	ATC	232;233;232	A;T;C	211;212;208	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4454	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2296	192.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1213	1215	GTG	231;230;232	G;T;G	211;204;210	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4454	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2296	192.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1213	1215	GTG	231;230;232	G;T;G	211;204;210	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4454	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2296	192.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1717	1719	ACC	239;237;236	A,G;C,A;C	211,1;215,1;216	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4454	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2296	192.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1771	1773	GCG	213;212;210	G;C;G,A	182;162;167,2	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4454	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2296	192.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1771	1773	GCG	213;212;210	G;C;G,A	182;162;167,2	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4454	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2296	192.9	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1894	1896	AGC	173;172;175	A;G;C	159;160;159	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4454	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2296	192.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1903	1905	GGC	171;168;170	G;G;C,A	149;149;149,1	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4454	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2296	192.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1921	1923	CCG	150;152;143	C,G;C,G;G,T,C	106,7;110,1;101,1,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6504	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3082	210.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1582	1584	CCG	213;214;213	C;C;G,T	187;195;191,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2496	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1745	141.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	527	527	C	179	C	164	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3240	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1504	214.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	432	434	GAA	254;256;255	G;A;A	238;243;242	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3240	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1504	214.0	0	.	p	.	0	N134D	NONSYN	400	402	AAT	720	722	GAT	254;253;258	G;A;T,G	228;228;227,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3240	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1504	214.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	843	845	TCA	252;252;256	T;C,A;A	233;232,1;238	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3240	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1504	214.0	0	.	p	.	0	A218V	NONSYN	652	654	GCC	972	974	GTC	263;264;264	G;T;C	239;242;243	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3240	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1504	214.0	0	.	p	.	0	F222S	NONSYN	664	666	TTT	984	986	TCT	276;276;279	T;C;T	257;260;262	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3240	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1504	214.0	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1302	1304	GCA	255;258;262	G;C;A	241;242;243	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3240	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1504	214.0	1	SNP	p	G120K	1	.	.	358	360	AAG	678	680	AAG	227;228;227	A;A;G	217;217;215	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3240	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1504	214.0	1	SNP	p	A121D	1	.	.	361	363	GAC	681	683	GAC	229;232;230	G;A;C	218;217;218	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3240	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1504	214.0	1	SNP	p	D121N	0	.	.	361	363	GAC	681	683	GAC	229;232;230	G;A;C	218;217;218	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12496	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4827	257.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1272	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1044	121.3	1	SNP	p	V57M	1	.	.	169	171	ATG	537	539	ATG	273;273;269	A;T;G	255;256;251	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
